Drug data last refreshed 3h ago · AI intelligence enriched 6d ago
OXYGEN, USP is a medical gas inhaled to treat hypoxemia and respiratory conditions requiring supplemental oxygen therapy. It is a non-pharmaceutical gas product approved as a New Drug Application (NDA) by the FDA. It works by increasing oxygen partial pressure in the blood to restore adequate tissue oxygenation.
At peak lifecycle stage with moderate competitive pressure (30%), indicating a mature but stable market with sustained demand and established commercial infrastructure.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Safety Study of Intravenous Hydrogen-Oxygen Ultrafine Bubbles in Adults
Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants
MolecuLight All-in-One Oxygenation Clinical Utility
Endoscopic COlorectal Mucosal Evaluation of Oxygen Tension
Impact of Intraoperative Oxygenation Practices on Patient Outcomes
Worked on OXYGEN, USP at Advanced Solutions Life Sciences? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on OXYGEN, USP offers career stability in a commodity healthcare market with focus on operational excellence, regulatory compliance, and logistics rather than product innovation. Roles emphasize supply chain, quality, distribution, and market access—ideal for professionals seeking long-term stability over rapid innovation-driven growth.